These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6849838

  • 1. Anaemia in myelofibrosis: its value in prognosis.
    Njoku OS, Lewis SM, Catovsky D, Gordon-Smith EC.
    Br J Haematol; 1983 May; 54(1):79-89. PubMed ID: 6849838
    [Abstract] [Full Text] [Related]

  • 2. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis.
    Ferrant A, Rodhain J, Cauwe F, Cogneau M, Beckers C, Michaux JL, Verwilghen R, Sokal G.
    Scand J Haematol; 1982 Nov; 29(5):373-80. PubMed ID: 7156888
    [Abstract] [Full Text] [Related]

  • 3. Detection of erythroid hypoplasia in myelofibrosis using erythrokinetic studies.
    Howarth JE, Waters HM, Hyde K, Geary CG.
    J Clin Pathol; 1989 Dec; 42(12):1250-2. PubMed ID: 2613917
    [Abstract] [Full Text] [Related]

  • 4. Quantitative studies of splenic erythropoiesis in polycythaemia vera and myelofibrosis.
    Pettit JE, Lewis SM, Williams ED, Grafton CA, Bowring CS, Glass HI.
    Br J Haematol; 1976 Nov; 34(3):465-75. PubMed ID: 990184
    [Abstract] [Full Text] [Related]

  • 5. Polycythaemia following splenectomy in myelofibrosis with myeloid metaplasia. A reorganization of erythropoiesis.
    Barosi G, Baraldi A, Cazzola M, Fortunato A, Palestra P, Polino G, Ramella S, Spriano P.
    Scand J Haematol; 1984 Jan; 32(1):12-8. PubMed ID: 6695146
    [Abstract] [Full Text] [Related]

  • 6. Staging of idiopathic myelofibrosis. Significance of haemoglobin value and reticulocyte count.
    Gustavsson P, Holm J, Wahlin A, Norberg B.
    Acta Med Scand; 1985 Jan; 218(5):487-91. PubMed ID: 4091048
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in myelofibrosis.
    Manoharan A, Smart RC, Pitney WR.
    Pathology; 1982 Oct; 14(4):455-61. PubMed ID: 7155637
    [Abstract] [Full Text] [Related]

  • 8. The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.
    Crisà E, Cilloni D, Elli EM, Martinelli V, Palumbo GA, Pugliese N, Beggiato E, Frairia C, Cerrano M, Lanzarone G, Marchetti M, Mezzabotta M, Boccadoro M, Ferrero D.
    Br J Haematol; 2018 Sep; 182(5):701-704. PubMed ID: 29984826
    [Abstract] [Full Text] [Related]

  • 9. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
    Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R.
    Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
    [Abstract] [Full Text] [Related]

  • 10. [Erythrocyte kinetics and bone marrow morphology in patients with osteomyelosclerosis and osteomyelofibrosis].
    Schulz K, Nowotny P, Bast G, Preussner S, Konrad H, Kiencke H.
    Acta Haematol; 1970 May; 43(5):280-90. PubMed ID: 4990105
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia.
    Fattizzo B, Zaninoni A, Gianelli U, Zanella A, Cortelezzi A, Kulasekararaj AG, Barcellini W.
    Am J Hematol; 2018 Aug; 93(4):E88-E91. PubMed ID: 29274091
    [No Abstract] [Full Text] [Related]

  • 12. The splenomegaly of myeloproliferative disorders: effects on blood volume and red blood count.
    Zhang B, Lewis SM.
    Eur J Haematol; 1989 Mar; 42(3):250-3. PubMed ID: 2924887
    [Abstract] [Full Text] [Related]

  • 13. Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis.
    Al-Ali HK, Stalbovskaya V, Gopalakrishna P, Perez-Ronco J, Foltz L.
    Leuk Lymphoma; 2016 Oct; 57(10):2464-7. PubMed ID: 26916563
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the haemodilution anaemia of splenomegaly.
    Blendis LM, Ramboer C, Williams R.
    Eur J Clin Invest; 1970 Mar; 1(1):54-64. PubMed ID: 5470478
    [No Abstract] [Full Text] [Related]

  • 15. Rabbit erythropoiesis during recovery from chronic anaemia induced by bleeding.
    Mayani H, Alba Lois L, Martínez Medellín J.
    Arch Invest Med (Mex); 1991 Mar; 22(3-4):317-22. PubMed ID: 1844118
    [Abstract] [Full Text] [Related]

  • 16. Different composition of the erythropoietic tissue in bone marrow, spleen and liver in myelofibrosis.
    Sjögren U.
    Acta Haematol; 1978 Mar; 59(4):231-6. PubMed ID: 417545
    [Abstract] [Full Text] [Related]

  • 17. Reticulocyte parameters of delta beta thalassaemia trait, beta thalassaemia trait and iron deficiency anaemia.
    Velasco-Rodríguez D, Alonso-Domínguez JM, González-Fernández FA, Villarrubia J, Sopeña M, Abalo L, Ropero P, Martínez-Nieto J, de la Fuente Gonzalo F, Cava F.
    J Clin Pathol; 2016 Feb; 69(2):149-54. PubMed ID: 26265587
    [Abstract] [Full Text] [Related]

  • 18. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].
    Bettini R, Redaelli S, Marzetta K, Maino C, Sala D, Saccà V, Gorini M.
    Recenti Prog Med; 2004 Feb; 95(7-8):358-64. PubMed ID: 15303545
    [Abstract] [Full Text] [Related]

  • 19. [Anemia in osteomyelosclerosis. Comparison between hematologic and erythrokinetic studies].
    Gelinsky P, Müller D.
    Klin Wochenschr; 1972 Jan 01; 50(1):21-32. PubMed ID: 5059000
    [No Abstract] [Full Text] [Related]

  • 20. Erythrokinetic studies as a guide to the value of splenectomy in primary myeloid metaplasia.
    Milner GR, Geary CG, Wadsworth LD, Doss A.
    Br J Haematol; 1973 Oct 01; 25(4):467-84. PubMed ID: 4752714
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.